These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study. Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605 [TBL] [Abstract][Full Text] [Related]
5. A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial. Ghanizadeh A; Sahraeizadeh A; Berk M Child Psychiatry Hum Dev; 2014; 45(2):185-92. PubMed ID: 23801256 [TBL] [Abstract][Full Text] [Related]
6. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study. Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Corey-Lisle PK; Aman MG J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):229-36. PubMed ID: 21663425 [TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Marcus RN; Owen R; Kamen L; Manos G; McQuade RD; Carson WH; Aman MG J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1110-1119. PubMed ID: 19797985 [TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. McDougle CJ; Stigler KA; Erickson CA; Posey DJ J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764 [TBL] [Abstract][Full Text] [Related]
11. Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders. Maloney A; Mick EO; Frazier J J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):357-9. PubMed ID: 24828130 [No Abstract] [Full Text] [Related]
12. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Swainston Harrison T; Perry CM Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633 [TBL] [Abstract][Full Text] [Related]
13. Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole. Wink LK; Early M; Schaefer T; Pottenger A; Horn P; McDougle CJ; Erickson CA J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):78-82. PubMed ID: 24564519 [TBL] [Abstract][Full Text] [Related]
14. Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change. Mankoski R; Stockton G; Manos G; Marler S; McQuade R; Forbes RA; Marcus R J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):572-6. PubMed ID: 24138011 [TBL] [Abstract][Full Text] [Related]
15. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China. Cui YH; Zheng Y; Yang YP; Liu J; Li J J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067 [TBL] [Abstract][Full Text] [Related]
17. Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials. Varni JW; Handen BL; Corey-Lisle PK; Guo Z; Manos G; Ammerman DK; Marcus RN; Owen R; McQuade RD; Carson WH; Mathew S; Mankoski R Clin Ther; 2012 Apr; 34(4):980-92. PubMed ID: 22444782 [TBL] [Abstract][Full Text] [Related]
18. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. Aman MG; Kasper W; Manos G; Mathew S; Marcus R; Owen R; Mankoski R J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):415-22. PubMed ID: 20973712 [TBL] [Abstract][Full Text] [Related]
19. A prospective open-label study of aripiprazole in fragile X syndrome. Erickson CA; Stigler KA; Wink LK; Mullett JE; Kohn A; Posey DJ; McDougle CJ Psychopharmacology (Berl); 2011 Jul; 216(1):85-90. PubMed ID: 21318565 [TBL] [Abstract][Full Text] [Related]
20. Aripiprazole in children and adolescents: clinical experience. Rugino TA; Janvier YM J Child Neurol; 2005 Jul; 20(7):603-10. PubMed ID: 16159529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]